Additional value of integrated F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile
Creators
- 1. Oncology Institute of Southern Switzerland, Department of Nuclear Medicine and PET/CT Centre, Bellinzona (Switzerland)
- 2. Galliera Hospital, Department of Nuclear Medicine, Genoa (Italy)
- 3. Galliera Hospital, Department of Histopathology, Genoa (Italy)
- 4. Galliera Hospital, Clinical Trial Unit, Office of the Scientific Director, Genoa (Italy)
- 5. Galliera Hospital, Department of Internal Medicine, Genoa (Italy)
- 6. Galliera Hospital, Department of Radiology, Genoa (Italy)
- 7. University Hospital Campus Bio Medico, Pathology Unit, Rome (Italy)
- 8. Lausanne University Hospital, Department of Nuclear Medicine and Molecular Imaging, Lausanne (Switzerland)
- 9. Galliera Hospital, Department of Endocrinology, Genoa (Italy)
- 10. Galliera Hospital, Department of Surgery, Genoa (Italy)
Description
The localization of hyperfunctioning parathyroid gland(s) (HPTG) in patients with primary hyperparathyroidism (PHPT) with negative or inconclusive first-line imaging is a significant challenge. This study aimed to evaluate the role of integrated F-choline PET/4D contrast-enhanced computed tomography (4DCeCT) in these patients, compare its detection rate and sensitivity with those of F-choline PET/CT and (4DCeCT), and analyse the association between choline metabolism and morphological, biochemical and molecular parameters of HPTG. We prospectively enrolled 44 PHPT patients with negative or inconclusive first-line imaging. F-Choline PET/CT and 4DCeCT were performed at the same time, and integrated F-choline PET/4DCeCT images were obtained after coregistration. Experienced physicians examined the images. The SUVratio and degree of contrast enhancement were recorded for each positive finding. Histopathology, laboratory and multidisciplinary follow-up were used as the standard of reference. Both the detection rates and sensitivities of the three imaging modalities were calculated retrospectively. Immunohistochemistry was performed to evaluate the molecular profile of HPTGs. F-Choline PET/4DCeCT was positive in 32 of 44 patients with PHPT (detection rate 72.7%), and 31 of 31 surgically treated patients (sensitivity 100%). These results were significantly (p 0.05) better than those of F-choline PET/CT (56.8% and 80%, respectively) and those of 4DCeCT (54.5 and 74%, respectively). A significant correlation between SUV and calcium level was found. In a multivariate analysis, only calcium level was significantly associated with F-choline PET/4DCeCT findings. SUVratio and Ki67 expression were significantly correlated. Integrated F-choline PET/4DCeCT should be considered as an effective tool to detect PHPT in patients with negative or inconclusive first-line imaging. Choline metabolism is correlated with both calcium level and Ki67 expression in HPTG. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-018-4147-4Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 46
- Journal Issue
- 3
- Journal Page Range
- p. 766-775
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 51000338
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOCHEMISTRY; CALCIUM; CHOLINE; COMPARATIVE EVALUATIONS; CONTRAST MEDIA; CORRELATIONS; DETECTION; FLUORINE 18; HYPERPARATHYROIDISM; METABOLISM; MULTIVARIATE ANALYSIS; PARATHYROID GLANDS; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY; SURGERY
- Descriptors DEC
- ALCOHOLS; ALKALINE EARTH METALS; AMMONIUM COMPOUNDS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CHEMISTRY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELEMENTS; EMISSION COMPUTED TOMOGRAPHY; ENDOCRINE DISEASES; ENDOCRINE GLANDS; EVALUATION; FLUORINE ISOTOPES; GLANDS; HOURS LIVING RADIOISOTOPES; HYDROXY COMPOUNDS; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; LIPOTROPIC FACTORS; MATERIALS; MATHEMATICS; MEDICINE; METALS; NANOSECONDS LIVING RADIOISOTOPES; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; QUATERNARY AMMONIUM COMPOUNDS; RADIOACTIVE MATERIALS; RADIOISOTOPES; STATISTICS; TOMOGRAPHY